Semax
ACTH-Derived Nootropic Peptide
A synthetic analogue of ACTH studied for neuroprotective and cognitive-enhancing properties.
Overview
Semax is a synthetic heptapeptide analogue of the ACTH(4-7) fragment. Research has investigated its neuroprotective, nootropic, and neurorestorative properties. It was developed in Russia and has been studied extensively for its effects on the central nervous system.
Research Information
Research on Semax has demonstrated its ability to increase BDNF (brain-derived neurotrophic factor) expression and modulate the dopaminergic and serotonergic systems. Studies have investigated its neuroprotective effects in models of ischemia and oxidative stress. Research has also explored its effects on memory, attention, and cognitive performance in animal models.
Research Dosage Reference
Research protocols use intranasal or subcutaneous administration. Standard vials contain 5mg lyophilized powder. All dosing information is for research reference only.
Related Research
Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.